Cara Therapeutics
Diane Roth has work experience as a Senior Consultant at Biobridges LLC since October 2018. Prior to that, they were an Associate Director of Clinical Project Management at Cara Therapeutics starting from October 2016. From March 2012 to October 2016, Diane worked as a Senior Clinical Study Manager at Regeneron Pharmaceuticals.
Diane Roth attended Salve Regina University from 1972 to 1976, where they obtained a Bachelor of Science in Nursing degree (BSN). Their field of study was Registered Nursing/Registered Nurse.
Cara Therapeutics
3 followers
Cara Therapeutics is an early commercial-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors, or KORs.